- Home
- GPCR vs CRTO Comparison
GPCR vs CRTO Comparison
Compare GPCR & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- CRTO
- Stock Information
- Founded
- GPCR 2016
- CRTO 2005
- Country
- GPCR United States
- CRTO France
- Employees
- GPCR N/A
- CRTO N/A
- Industry
- GPCR
- CRTO Advertising
- Sector
- GPCR
- CRTO Consumer Discretionary
- Exchange
- GPCR Nasdaq
- CRTO Nasdaq
- Market Cap
- GPCR 1.2B
- CRTO 1.1B
- IPO Year
- GPCR 2023
- CRTO 2013
- Fundamental
- Price
- GPCR $33.00
- CRTO $21.40
- Analyst Decision
- GPCR Strong Buy
- CRTO Buy
- Analyst Count
- GPCR 8
- CRTO 9
- Target Price
- GPCR $69.57
- CRTO $38.67
- AVG Volume (30 Days)
- GPCR 838.8K
- CRTO 495.1K
- Earning Date
- GPCR 11-06-2025
- CRTO 10-29-2025
- Dividend Yield
- GPCR N/A
- CRTO N/A
- EPS Growth
- GPCR N/A
- CRTO 83.79
- EPS
- GPCR N/A
- CRTO 3.00
- Revenue
- GPCR N/A
- CRTO $1,956,800,000.00
- Revenue This Year
- GPCR N/A
- CRTO N/A
- Revenue Next Year
- GPCR N/A
- CRTO $1.84
- P/E Ratio
- GPCR N/A
- CRTO $7.15
- Revenue Growth
- GPCR N/A
- CRTO 0.53
- 52 Week Low
- GPCR $13.22
- CRTO $19.50
- 52 Week High
- GPCR $40.06
- CRTO $47.27
- Technical
- Relative Strength Index (RSI)
- GPCR 64.72
- CRTO 48.91
- Support Level
- GPCR $31.50
- CRTO $21.94
- Resistance Level
- GPCR $34.50
- CRTO $23.36
- Average True Range (ATR)
- GPCR 1.72
- CRTO 0.87
- MACD
- GPCR 0.29
- CRTO 0.18
- Stochastic Oscillator
- GPCR 85.30
- CRTO 38.71
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.